N
65.69
5.34 (8.85%)
| Penutupan Terdahulu | 60.35 |
| Buka | 63.10 |
| Jumlah Dagangan | 862,402 |
| Purata Dagangan (3B) | 1,015,323 |
| Modal Pasaran | 1,336,238,976 |
| Harga / Jualan (P/S) | 13.95 |
| Harga / Buku (P/B) | 13.66 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -152.49% |
| Margin Operasi (TTM) | -424.15% |
| EPS Cair (TTM) | -9.45 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -51.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1,358.71% |
| Nisbah Semasa (MRQ) | 3.24 |
| Aliran Tunai Operasi (OCF TTM) | -176.87 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -47.84 M |
| Pulangan Atas Aset (ROA TTM) | -26.80% |
| Pulangan Atas Ekuiti (ROE TTM) | -189.46% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Nektar Therapeutics | Menaik | Menaik |
AISkor Stockmoo
-1.1
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | 0.0 |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.0 |
| Purata | -1.10 |
|
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.29% |
| % Dimiliki oleh Institusi | 67.11% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 121.00 (Jefferies, 84.20%) | Beli |
| Median | 103.50 (57.56%) | |
| Rendah | 100.00 (BTIG, 52.23%) | Beli |
| Purata | 107.00 (62.89%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 61.53 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 26 Nov 2025 | 102.00 (55.27%) | Beli | 65.69 |
| Jefferies | 26 Nov 2025 | 121.00 (84.20%) | Beli | 65.69 |
| B. Riley Securities | 23 Sep 2025 | 105.00 (59.84%) | Beli | 59.60 |
| BTIG | 19 Sep 2025 | 100.00 (52.23%) | Beli | 55.14 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ROBIN HOWARD W | - | 60.35 | -2,207 | -133,192 |
| WILSON MARK ANDREW | - | 60.35 | -630 | -38,021 |
| ZALEVSKY JONATHAN | - | 60.35 | -1,157 | -69,825 |
| Jumlah Keseluruhan Kuantiti Bersih | -3,994 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -241,038 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 60.35 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| ROBIN HOWARD W | Pegawai | 25 Nov 2025 | Jual (-) | 2,207 | 60.35 | 133,192 |
| WILSON MARK ANDREW | Pegawai | 25 Nov 2025 | Jual (-) | 630 | 60.35 | 38,021 |
| ZALEVSKY JONATHAN | Pegawai | 25 Nov 2025 | Jual (-) | 1,157 | 60.35 | 69,825 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |